SI1420822T2 - Modified vaccinia virus ankara for the vaccination of neonates - Google Patents

Modified vaccinia virus ankara for the vaccination of neonates

Info

Publication number
SI1420822T2
SI1420822T2 SI200330925T SI200330925T SI1420822T2 SI 1420822 T2 SI1420822 T2 SI 1420822T2 SI 200330925 T SI200330925 T SI 200330925T SI 200330925 T SI200330925 T SI 200330925T SI 1420822 T2 SI1420822 T2 SI 1420822T2
Authority
SI
Slovenia
Prior art keywords
neonates
vaccination
vaccinia virus
modified vaccinia
virus ankara
Prior art date
Application number
SI200330925T
Other languages
Slovenian (sl)
Other versions
SI1420822T1 (en
Inventor
Paul Chaplin
Mark Suter
Mathias Ackermann
Marco Franchini
Sabine Vollstedt
Hans Peter Hefti
Original Assignee
Bavarian Nordic A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic A/S filed Critical Bavarian Nordic A/S
Priority claimed from EP03732280.7A external-priority patent/EP1420822B2/en
Publication of SI1420822T1 publication Critical patent/SI1420822T1/en
Publication of SI1420822T2 publication Critical patent/SI1420822T2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/275Poxviridae, e.g. avipoxvirus
    • A61K39/285Vaccinia virus or variola virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24161Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
SI200330925T 2002-04-19 2003-04-16 Modified vaccinia virus ankara for the vaccination of neonates SI1420822T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200200590 2002-04-19
EP03732280.7A EP1420822B2 (en) 2002-04-19 2003-04-16 Modified vaccinia virus ankara for the vaccination of neonates
PCT/EP2003/003994 WO2003088994A2 (en) 2002-04-19 2003-04-16 Modified vaccinia virus ankara for the vaccination of neonates

Publications (2)

Publication Number Publication Date
SI1420822T1 SI1420822T1 (en) 2007-10-31
SI1420822T2 true SI1420822T2 (en) 2017-11-30

Family

ID=38442445

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330925T SI1420822T2 (en) 2002-04-19 2003-04-16 Modified vaccinia virus ankara for the vaccination of neonates

Country Status (1)

Country Link
SI (1) SI1420822T2 (en)

Also Published As

Publication number Publication date
SI1420822T1 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
EP1648233A4 (en) Mutants of vaccinia virus as oncolytic agents
GB0306611D0 (en) Novel vaccine
GB0202901D0 (en) Novel vaccine
AU2003219057A8 (en) Recombinant drug-sensitive vaccinia virus as smallpox vaccine
AU2003285320A8 (en) Vaccine
AU2003289603A1 (en) Tumor vaccine
PT1372712E (en) Equine herpesvirus vaccine
AU2003249059A8 (en) Use of vaccinia virus deleted for the e3l gene as a vaccine vector
IL158549A0 (en) Smallpox vaccine
ITMI20021031A1 (en) PROCEDURE FOR PREPARING POLYCARBONATE-POLYOLS
GB0209878D0 (en) Vaccine
SI1420822T2 (en) Modified vaccinia virus ankara for the vaccination of neonates
AU2003213167A8 (en) Sequence analysis of the tetravalent rotavirus vaccine
AU2002347346A8 (en) Dna vaccine
GB0215621D0 (en) Improved poxvirus vaccines
AU2002322013A1 (en) Therapeutic dna vaccination
GB0129338D0 (en) Vaccination
AU2002333499A1 (en) Vaccine against mycobacterial-induced diseases
ITMI20020620A1 (en) PROCEDURE FOR THE PREPARATION OF ALCHYL-BENZOATES FOR THE EXTERIFICATION OF BENZOIL-FLUORIDES
ITTO20020465A0 (en) PROCEDURE FOR THE PREPARATION OF DOXOPHYLLIN.
GB0223829D0 (en) DNA vaccine
AU2002238396A1 (en) Tumor vaccine
GB0226717D0 (en) DNA vaccination
GB0104538D0 (en) Novel Vaccine
GB0104542D0 (en) Novel vaccine